GW Pharma (GWPH) Posts Smaller-than-Expected Q1 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
GW Pharmaceuticals plc Reports First Quarter 2017 Financial Results and Operational Progress
February 7, 2017 7:00 AM EST- Epidiolex® NDA submission and launch preparation on track -- New Positive Phase 2 glioma data further demonstrates value of cannabinoid pipeline - - Conference call today at 8:30 a.m. EST -
LONDON, Feb. 07, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced financial results for the first... More
